All enrolled patients who been given not less than a person dose of zosuquidar or placebo throughout induction were monitored with the event of adverse occasions (439 patients, 219 on zosuquidar and 210 on placebo). The most common adverse situations were connected with the duration of prolonged and considerable myelosuppression https://sir-cooh33872.blogdal.com/28439177/helping-the-others-realize-the-advantages-of-imdk